Advertisement

Topics

New England Compounding Center Company Profile

23:55 EST 14th December 2018 | BioPortfolio

“New England Compounding Center (NECC) is working closely with the Massachusetts Board of Pharmacy, the Centers for Disease Control and the U.S. Food and Drug Administration on their investigation into the cause of infection in patients who received injections of methylprednisolone acetate. As part of this process, NECC has initiated a series of recalls encompassing all methylprednisolone acetate products - as well as other injectable medications - distributed from our facility in Framingham, Massachusetts. We also understand the FDA – as a precautionary measure - has suggested to medical professionals that they do not use any NECC products at this time, although there is no indication of any potential issues with other products. As previously announced, we have voluntarily suspended operations while we assist authorities in this investigation. The fatalities and illnesses confirmed today by the CDC and FDA are tragic. The thoughts and prayers of everyone employed by NECC are with those who have been affected.”


News Articles [1103 Associated News Articles listed on BioPortfolio]

Former Pharma Tech Says Compounding Center Fudged Expiration Dates

NewsA witness testified that it was “routine practice” for employees at the New England Compounding Center to falsify expiration dates on drugs.

STAT Plus: Pharmalittle: Former compounder employees convicted; Purdue must fork over secret records

Four former employees and an owner of the New England Compounding Center were convicted on charges including mail fraud and conspiracy to defraud the U.S.

Vertex Rejects England’s Orkambi Offer

Vertex has rejected the “final offer” put forward by the National Health Service in England for its cystic fibrosis drugs...   

Compounding Center Employee: Safety was ‘Secondary’

ArticleNECC employees stated that safety measures were ignored and records were falsified in order to bypass waiting times for proper quality tests.

Witness: Compounding Center Used Fake Names on Drug Prescriptions

NewsA former NECC salesman says the firm used falsified names, such as Wayne Gretzky and Johnny Cash, on prescriptions.

RXQ Compounding Raises $7M for FDA Approved 503B Outsourcing Facility

RXQ Compounding, LLC, an Athens, Ohio-based manufacturer of sterile and non-sterile medications licensed to ship to 38 states and Washington, D.C., announced it has raised $7 million in Series A fundi...

NHS England appoints national clinical advisor for primary care

NHS England has appointed a specialist GP to encourage the spread of innovations that integrate health and social care throughout England.

Over 400,000 sexually transmitted infections reported in England in 2017, PHE report reveals

The number of confirmed cases of gonorrhoea and syphilis in England in 2017 rose by 22% and 20%, respectively, according to data released by Public Health England.

PubMed Articles [1717 Associated PubMed Articles listed on BioPortfolio]

The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.

Medication compounding gained national attention in the fall of 2012 after contaminated compounded medications produced in the New England Compounding Center infected 800 people with fungal meningitis...

Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy.

The International Academy of Compounding Pharmacists Foundation held a student essay contest in the Spring of 2018. Two great submissions were chosen to receive an award. This article features one of ...

Yes to Appropriate Compounding, No to Illegal Compounding.

Dermatology is often described as a "visual" specialty. While it is true that many of our diagnoses can be made based on a relatively quick recognition of morphology, such a characterization of our pr...

Compounding from a Pharmacy Student's Perspective.

The International Academy of Compounding Pharmacists' Foundation held a student essay contest in the Spring of 2018. Two great submissions were chosen to receive an award. This article features one of...

Basics of Compounding-Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1.

Self-emulsifying Drug Delivery Systems are being introduced and are increasing in popularity for improving the solubility of lipophilic drugs. They are isotropic mixtures of drug, oil, surfactant and/...

Clinical Trials [1854 Associated Clinical Trials listed on BioPortfolio]

Improving the Management of Drug Resistant Tuberculosis in the UK

The 'rising tide' of antimicrobial resistance is a source of concern across most infectious diseases. In the UK, for example, 6.8% of the ~8,500 tuberculosis patients seen in 2012 were res...

PREG-MS: New England MS Pregnancy Registry

The purpose of the study is to develop a detailed pregnancy registry of patients with Multiple Sclerosis in the New England states. Women with a diagnosis of MS that are either pregnant or...

Comparison of I-Gel to the Laryngeal Mask Airway

The purpose of this study is to evaluate a new disposable supra-glottic airway device, the i-gel airway (Intersurgical Ltd., Wokingham, England). We propose to test its ease of insertion,...

NHS AAA Screening Programme Data Linkage With HES and ONS Datasets

An abdominal aortic aneurysm (AAA) is a dilation of the aorta, defined as an aortic diameter of ≥3cm. It is a significant cause of death internationally and in England each year causes c...

Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England Smoking Cessation and Reduction in Pregnancy Trial (SCRIPT)

Smoking during pregnancy is the single most preventable cause of illness and death among mothers and infants. Because of the stigma associated with tobacco use during pregnancy, pregnant w...

Companies [1634 Associated Companies listed on BioPortfolio]

New England Compounding Center

“New England Compounding Center (NECC) is working closely with the Massachusetts Board of Pharmacy, the Centers for Disease Control and the U.S. Food and Drug Administration ...

New England Compounding Pharmacy, Inc.

HEXPOL Compounding LLC

Sixteen locations in North America include legacy names such as Gold Key Processing, Burton Rubber Processing, Colonial Rubber Works, Robbins LLC, Kardoes Rubber, HEXPOL Silicone ...

California Pharmacy

Welcome to California Pharmacy & Compounding Center. We are dedicated to serving the special needs of physicians and their patients through Custom Prescription Compounding. In business since 1975, we ...

The Cosmetic Enhancement Center of New England

The Cosmetic Enhancement Center of New England is Portland Maine’s finest Physician owned minimally invasive, Cosmetic Treatment facility. CEC is owned and operated by Dr. Ma...

More Information about "New England Compounding Center" on BioPortfolio

We have published hundreds of New England Compounding Center news stories on BioPortfolio along with dozens of New England Compounding Center Clinical Trials and PubMed Articles about New England Compounding Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of New England Compounding Center Companies in our database. You can also find out about relevant New England Compounding Center Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record